(lp0
S'Prothena Corporation plc : Press Release Nasdaq - Apr 2, 2017 DUBLIN, Ireland, April 02, 2017  -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today&nbsp;...'
p1
aS'Prothena Corporation plc  Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 Prothena Corporation plc  traded on unusually high volume on Mar. 17, as the stock lost 0.55% to close at $53.89. On the day, Prothena Corporation plc saw 543,071 shares trade hands on 3,132 trades. Considering that the stock averages only a ...'
p2
aS'52.54 MarketWatch - Apr 2, 2013 Can Prothena  Pull a Surprise This Earnings Season? Prothena Corporation plc  is scheduled to report fourth-quarter 2016 results on Feb 14 after the market closes.'
p3
aS'Is there Upside to Prothena Corporation plc  ? Rockville Register - 18 hours ago In the most recent trading session, Prothena Corporation plc  shares saw a move of +0.86%. Covering Wall Street analysts have a consensus target price of $74.80 on the stock.'
p4
aS"Hot Stocks Among Investors: Prothena Corporation plc , BioLine Rx Ltd  Post Analyst - Apr 14, 2017 Prothena Corporation plc  last session's volume of 0.37 million shares was higher than its average volume of 0.31 million shares.Zacks: Brokerages Anticipate Prothena Co. PLC  Will Announce Quarterly ... - The Cerbat GemRussell Investments Group Ltd. Acquires Shares of 10661 Prothena Co. PLC  - BBNS"
p5
aS'Prothena Announces Appointment of Chief Regulatory Officer GlobeNewswire  - Dec 15, 2016 DUBLIN, Ireland, Dec. 15, 2016  -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, announced&nbsp;...'
p6
aS'Market Focus: Checking in on Shares of Prothena Corporation PLC  Piedmont Register - 13 hours ago Traders watching the charts on Prothena Corporation PLC  may be interested in viewing the RSI. In terms of Relative Strength Index, the 14-day RSI is currently sitting at 49.44, the 7-day is 54.62, and the 3-day is spotted at 76.93.'
p7
aS'Sell-side Viewpoints on Prothena Corporation plc  The Herald - Apr 14, 2017 Out of the 7 covering Street analysts providing stock ratings for Prothena Corporation plc , 7 have shares listed as a Strong Buy while 0 analysts have the stock rated a Buy.'
p8
aS'Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief ... GlobeNewswire  - Oct 3, 2016 DUBLIN, Ireland, Oct. 03, 2016  -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, announced&nbsp;...'
p9
aS"Results for Prothena's Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 ... GlobeNewswire  - Mar 9, 2017 DUBLIN, Ireland, March 09, 2017  -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today&nbsp;..."
p10
a.